Video

Q&A with Marla Dubinsky: Safety Questions for IBD

Author(s):

Marla Dubinsky, MD, Mount Sinai Hospital, reviewed some of the more common side effects associated with the more common therapies that most IBD experts discuss.

Marla Dubinsky, MD, Mount Sinai Hospital, reviewed some of the more common side effects associated with the more common therapies that most IBD experts discuss.

According to Dubinsky, maybe, most of the risk tied to the use of biologic therapy is tied to the combination with the immunomodulators as some of the safety signals.

Related Videos
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Braden Kuo, MD | Credit: Mass Gen
Satish Rao, MD, PhD | Credit: ACG
Anthony Kerbage, MD | Credit: ResearchGate
© 2024 MJH Life Sciences

All rights reserved.